Loading clinical trials...
Loading clinical trials...
A Phase I Clinical Study of CCX168 in Japanese and Caucasian Healthy Adult Males
Conditions
Interventions
CCX168
Placebo
Locations
1
Japan
Sumida Hospital, SOUSEIKAI Global Clinical Research Center
Sumida City, Tokyo, Japan
Start Date
October 23, 2017
Primary Completion Date
January 26, 2018
Completion Date
September 20, 2018
Last Updated
August 14, 2023
NCT06978647
NCT07212322
NCT04871191
NCT02749292
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions